COLUMN GROUP III, LP
CIK 1668159 · last filed 2024-04-17
COLUMN GROUP III, LP is a corporate insider who has filed 17 SEC Form 4 insider transactions across 3 companies since 2019. The most recent filing, for TNYA, was dated Feb 25, 2026. Across all open-market trades the lifetime net is +$73.7M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $3.0M across reported positions. The firm reports its address in San Francisco, CA. 77 SEC filings were submitted jointly with COLUMN GROUP III-A, LP.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$3.04M
3
17
$73.67M
Filer Profile
SUITE 500
SAN FRANCISCO, CA 94158
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Surrozen, Inc./DE (SRZNW) Delisted | 10%+ Owner | 289,549 | $0.00 | $434 | $18.00M | 2 | 2024-04-17 |
| TNYA | 10%+ Owner | 4,414,720 | $0.69 | $3.04M | $1.05M | 2 | 2023-01-23 |
| NGM BIOPHARMACEUTICALS INC (NGM) Delisted | 10%+ Owner | 11,118,333 | $1.54 | $17.12M | $54.63M | 9 | 2022-12-14 |
Recent Filings
17 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-02-25 | TNYA | Notice (144) | −939,273 | -$565.4K | EDGAR |
| 2026-02-20 | TNYA | Notice (144) | −1,408,910 | -$872.5K | EDGAR |
| 2026-02-11 | TNYA | Notice (144) | −657,627 | -$447.0K | EDGAR |
| 2026-02-10 | TNYA | Notice (144) | −1,408,910 | -$1.11M | EDGAR |
| 2024-04-17 | Surrozen, Inc./DE (SRZNW) Delisted | Buy (P) | +580,644 | $9.00M | EDGAR |
| 2024-04-08 | Surrozen, Inc./DE (SRZNW) Delisted | Buy (P) | +580,644 | $9.00M | EDGAR |
| 2023-01-23 | TNYA | Buy (P) | +418,434 | $1.05M | EDGAR |
| 2022-12-14 | NGM BIOPHARMACEUTICALS INC (NGM) Delisted | Buy (P) | +3,000 | $14.9K | EDGAR |
| 2022-11-07 | NGM BIOPHARMACEUTICALS INC (NGM) Delisted | Buy (P) | +1,391,480 | $6.84M | EDGAR |
| 2022-05-26 | NGM BIOPHARMACEUTICALS INC (NGM) Delisted | Buy (P) | +488,960 | $6.56M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.